誘発性多能幹細胞による長いQT症候群のモデル化
Ilanit Itzhaki1, Leonid Maizels, Irit Huber
1Sohnis Family Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, POB 9649, Haifa 31096, Israel.
Nature
|January 18, 2011
まとめ
患者特有のヒト誘発性多能幹細胞 (iPSC) は,長いQT症候群 (LQTS) を成功裏にモデル化し,心臓のカリウム流量低下と不律を明らかにしました. このiPSCモデルは,遺伝性心疾患とパーソナライズド医療のための薬剤の試験に役立ちます.
科学分野:
- 心血管科学の研究について
- 幹細胞生物学 幹細胞生物学
- 遺伝学 遺伝学とは
背景:
- 生まれながらの長QT症候群 (LQTS) は,異常な心拍数と突然の心臓死を引き起こす遺伝疾患です.
- 患者特有のヒト誘発性多能幹細胞 (iPSCs) は,疾患モデリングと薬剤発見のための強力なツールを提供します.
研究 の 目的:
- 2型LQTSの患者から患者特有のヒトiPSCラインを開発し,特徴づけること.
- iPSC-derived cardiomyocytesを使用してLQTSのフェノタイプをインビトロでモデル化する.
- このモデルを使用して,潜在的な治療薬の評価を行う.
主な方法:
- KCNH2遺伝子変異を有するLQTS患者のiPSCの生成.
- iPSCsを心筋細胞に区分する.
- 心臓機能を評価するための電気生理学的記録 (パッチクランプ,マルチ電極配列)
- iPSCから派生した心臓組織に様々な薬物クラスの薬理学的試験.
主要な成果:
- LQTS患者からのiPSC由来心筋細胞は,アクションポテンシャル期間が延長され,I(Kr) 電流が減少した.
- LQTSから派生した細胞は,早期のデポラライゼーションと誘発性心拍不全を含むリズム変異性を示した.
- iPSCモデルは,カリウムチャネルブロッカーの効果を予測し,潜在的改善剤を特定することに成功した.
結論:
- 人間のiPSC技術は,LQTSのような遺伝性心疾患の機能的フェノタイプを正確にモデル化することができます.
- この患者特有のiPSC由来心臓モデルは,疾患のメカニズムを研究し,新しい治療戦略を特定するのに価値があります.
- iPSC技術は,パーソナライズド医療と心臓血管疾患における薬物開発の有望なアプローチを表しています.
さらに関連する動画
関連する概念動画
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.